Ensign Peak Advisors, Inc - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 123 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ensign Peak Advisors, Inc ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$425,259
+59.2%
18,550
+14.5%
0.00%0.0%
Q2 2023$267,138
-91.5%
16,200
-85.1%
0.00%
-85.7%
Q4 2022$3,161,325
+1053.8%
108,562
+871.9%
0.01%
+600.0%
Q3 2022$274,000
+124.6%
11,170
-61.9%
0.00%
Q2 2022$122,000
+106.8%
29,345
+476.5%
0.00%
Q1 2022$59,000
+15.7%
5,0900.0%0.00%
Q4 2021$51,000
-93.6%
5,090
-87.6%
0.00%
-100.0%
Q2 2021$801,000
-7.9%
40,8910.0%0.00%0.0%
Q1 2021$870,000
+38.3%
40,891
+93.1%
0.00%
+100.0%
Q4 2020$629,000
+37.0%
21,1730.0%0.00%0.0%
Q3 2020$459,00021,1730.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 2,075,000$47,569,3755.56%
NEA Management Company, LLC 2,909,956$66,710,7415.15%
Opaleye Management Inc. 653,000$14,970,0254.87%
Frazier Life Sciences Management, L.P. 2,371,304$54,362,1443.61%
VR Adviser, LLC 1,090,000$24,988,2502.63%
RA Capital Management 5,676,067$130,123,8362.56%
Samsara BioCapital, LLC 345,293$7,915,8422.42%
SILVERARC CAPITAL MANAGEMENT, LLC 260,537$5,972,8111.81%
Logos Global Management LP 400,000$9,170,0001.22%
Cormorant Asset Management, LP 850,000$19,486,2501.14%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders